In conclusion, we propose that the MKL-1-miR-17-CD44 pathway is an important determinant of the progression of gastric cancer stem cells, and targeting this pathway may provide new therapeutic opportunities for the treatment of gastric cancer. Here, CD44 is linked to gastric cancer.